This compound is an Fmoc-protected beta-alanine derivative used as a building block in solid-phase peptide synthesis. Its structure includes a fluorenylmethoxycarbonyl (Fmoc) protecting group, a beta-alanine backbone, and a terminal carboxylic acid.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 35737-10-1
N-Fmoc-6-aminohexanoic acid
research compound
5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid 1-(9H-fluoren-9-ylmethyl) ester
research compound
5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester
pharmaceutical intermediate
5,8,11,14,17,20-Hexaoxa-2-azatricosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester
research compound
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(1,3-dioxoisoindolin-2-yl)hexanoic acid
pharmaceutical intermediate
N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine
pharmaceutical intermediate
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-methoxypyridin-3-yl)propanoic acid
pharmaceutical intermediate
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxy-2-methylphenyl)propanoic acid
pharmaceutical intermediate
3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
LINBWYYLPWJQHE-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCC(=O)O